Ads
related to: Stelara
Search results
IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
Investor's Business Daily· 2 hours agoIn the patients who worsened while taking a prior biologic, 43.4% of mirikizumab patients entered...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 11 hours agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 4 hours agoLiving Life With Psoriasis As with many chronic illnesses, psoriasis cannot be cured, but it can be...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 42 minutes agoTotal revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year. Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 days agoExcluding sales from J&J’s COVID-19 vaccine, operational sales grew 8.3%. Higher sales of key...
May 15, 2024, R-C Letters to the Editor
The Record-Courier· 7 days agoLetters to the Editor
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 5 days agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Earnings call: AbbVie projects robust growth and diversified pipeline By Investing.com
Investing.com· 6 days agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...
Benzinga· 22 hours agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech ALVO, today announced the availability of SIMLANDI (adalimumab-ryvk) injection ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
WFRV 5 Green Bay· 4 days ago...disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)- Data to be presented from the SEQUENCE head-to-head trial comparing risankizumab (SKYRIZI®) versus ustekinumab (STELARA®) in Crohn's disease include an economic...
Ad
related to: Stelara